403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Docmorris Publishes Invitation To The Annual General Meeting
|
DocMorris AG
/ Key word(s): AGMEGM
DocMorris publishes invitation to the Annual General Meeting 16.04.2026 / 07:00 CET/CEST Frauenfeld, 16 April 2026 Press release DocMorris publishes invitation to the Annual General Meeting
DocMorris published encouraging figures for the first quarter of 2026 today. These demonstrate that the strategy and measures are taking effect and that DocMorris is on track. To ensure this positive trend is not interrupted, DocMorris presented three new, independent candidates on 3 March as part of the ongoing renewal. With their expertise – particularly in finance, artificial intelligence, and corporate governance – Thomas Bucher, Nicole Formica-Schiller and Dr Thomas Reutter possess the right expertise for the orderly renewal of the Board and for the next phase of DocMorris' development. Together with the existing Board members Prof. Dr Andréa Belliger, Walter Oberhänsli and Florian Seubert, they enjoy the full confidence of the well-established management team. Minority shareholder seeks control through the back door At the end of March, the Polish investor Jacek Szwajcowski, through CEPD N.V., which he controls, submitted proposals for the Annual General Meeting to elect three of his own representatives to the Board and to take over the chairmanship. If he succeeds, he will gain full control of DocMorris-at the expense of all other shareholders. CEPD N.V. has only been a shareholder of DocMorris since spring 2025 and currently holds around 15% of the shares. Jacek Szwajcowski was repeatedly offered the opportunity for CEPD N.V. to nominate one candidate for the Board of Directors – he never took up this offer. Furthermore, CEPD N.V. provided no information regarding its strategic intentions or its obligations to financing partners and lenders, despite repeated enquiries. Following the proposals submitted by CEPD N.V., the reason is now clear: Szwajcowski is seeking a hostile takeover through the back door. Anyone who appoints three out of six Board members and the Chairman controls the company at will. This runs counter to the interests of all other shareholders. Anyone seeking a change of control must do so via a public takeover bid with a substantial premium on the share price. Only an independent Board can fulfil its duties of loyalty and care towards all shareholders If the majority of the Board of Directors were to serve an opaque minority shareholder, the Board could no longer fulfil its duties of loyalty and care towards the shareholders as a whole. All candidates nominated for election by the DocMorris Board of Directors have confirmed that they will serve their terms only on the condition that they can perform their duties independently and responsibly, in accordance with the principles of good corporate governance and in the best interests of all shareholders. Call to shareholders to safeguard the independence and continuity of DocMorris The Board of Directors recommends that shareholders elect the candidates it has nominated and reject the nominations put forward by CEPD N.V. This will safeguard DocMorris' independence, strategic continuity and sustainable value creation for all shareholders. DocMorris will send the invitation documents for the General Meeting, together with further information, to shareholders registered in the share register in the coming days. These are also available online and are continuously updated on the website at . Shareholders not yet registered are urged to have themselves entered in the share register by 7 May in order to exercise their voting rights. Investors and analyst contact Kelvin Jörn, Head of Investor Relations Email:..., phone: +41 52 560 58 10 Media contact Torben Bonnke, Director Communications Email:..., phone: +49 171 864 888 1 Agenda
DocMorris [1] Corporation of European Pharmaceutical Distributors N.V., Amsterdam, the Netherlands
End of Media Release |
| Language: | English |
| Company: | DocMorris AG |
| Walzmühlestrasse 49 | |
| 8500 Frauenfeld | |
| Switzerland | |
| ISIN: | CH0042615283 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2309310 |
2309310 16.04.2026 CET/CEST |
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment